Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity® [NA]
A randomized, head-to-head comparison of Biomatrix Flex and Resolute Integrity drug-eluting stents in patients with coronary artery disease …
-
FDA approval · 2013-09-20FDA Approved: NITROGLYCERIN LINGUAL — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Nitroglycerin Lingual as a generic product under an original ANDA from Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2013-09-12FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging [NA]
The study evaluating transmyocardial laser revascularization with cardiovascular magnetic resonance imaging was terminated.
-
FDA approval · 2013-08-30FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approves Teva Pharmaceuticals’ supplemental application for amlodipine besylate (generic) under ANDA076846. This action represents an ap…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-08-30FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for amlodipine besylate from Epic Pharma, enabling the generic product to be marketed.
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: SORT-OUT V - Randomised Clinical Comparative Study of the Nobori and the Cypher Stent. [Phase 4]
Phase 4 randomized trial comparing Nobori and Cypher coronary stents in patients with coronary artery disease and angina.
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients [Phase 4]
A Phase 4 trial evaluated the effect of metoprolol succinate on heart rate in stable angina patients; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Comparison of Cypher Select and Taxus Express Coronary Stents [Phase 4]
A Phase 4 trial comparing Cypher Select and Taxus Express coronary stents has completed, sponsored by Aarhus University Hospital Skejby.
-
FDA approval · 2013-07-29FDA Approved: RANOLAZINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic Ranolazine for chronic angina pectoris under the Original Application (ANDA 201046).
-
FDA approval · 2013-07-25FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Procardia XL (nifedipine) from Pfizer Laboratories Div Pfizer Inc.
-
FDA label_change · 2013-07-24FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Norvasc (amlodipine besylate) resulting in updates to the product labeling.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Ranolazine, Ethnicity and the Metabolic Syndrome [Phase 4]
Phase 4 clinical trial evaluating ranolazine across ethnic groups in patients with coronary artery disease and angina, including metabolic s…
-
FDA approval · 2013-07-09FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application for amlodipine besylate, confirming the approval of the ANDA supplement for t…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions [Phase 1]
This document reports the completion of a Phase 1 bioequivalence study evaluating metoprolol succinate extended-release tablets 200 mg under…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions [Phase 1]
This Phase 1 trial evaluated bioequivalence of metoprolol succinate extended-release 200 mg under fed conditions and has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Clinical trial update for Amlodipine/Atorvastatin (Caduet) under regulatory post-marketing commitments; study completed with results posted …
-
FDA approval · 2013-05-28FDA Approved: METOPROLOL TARTRATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' metoprolol tartrate as an original generic product (ANDA 202871).
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Safety Study of Kudiezi(Yueanxin,a Chinese Medicine Injection)Used in Hospitals in China
This entry describes a safety-focused clinical trial of Kudiezi (Yueanxin), a Chinese medicine injection, being used in hospitals in China.
-
CLINICAL_TRIALS safety_alert · 2013-05-14Clinical Trial Update: Safety Study of DanshenDuofensuanyan(a Chinese Medicine Injection)Used in Hospitals in China
Safety study update for DanshenDuofensuanyan (Chinese medicine injection) used in hospitals in China, focusing on safety in patients with co…
-
FDA approval · 2013-05-02FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva Pharmaceuticals' supplemental application for amlodipine besylate under ANDA 076846.
-
FDA approval · 2013-04-29FDA Approved: METOPROLOL — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter's generic metoprolol tartrate (METOPROLOL TARTRATE) as an Original Application. The approval supports the generic produc…
-
FDA approval · 2013-04-25FDA Approved: NIFEDIPINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a generic nifedipine product from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under ANDA 202644.
-
CLINICAL_TRIALS research · 2013-04-17Clinical Trial Update: Angina in Non Coronary Artery Disease
Clinical trial update related to angina in non-coronary artery disease, involving angina pectoris, microvascular angina, and variant (Prinzm…
-
FDA approval · 2013-03-18FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited under an ANDA.